Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1052133
rs1052133
OGG1 ; CAMK1
0.040 GeneticVariation BEFREE Our present data suggest a possible interaction between the OGG1 Ser326Cys polymorphism and smoking in HNSCC. 16381036

2006
dbSNP: rs1052133
rs1052133
OGG1 ; CAMK1
0.040 GeneticVariation BEFREE Our results demonstrate that Ser326Cys variant genotype is associated with an increased risk of SCCHN in north India. 21986195

2011
dbSNP: rs1052133
rs1052133
OGG1 ; CAMK1
0.040 GeneticVariation BEFREE Our meta-analysis results indicated that <i>hOGG1</i> Ser326Cys polymorphism may be associated with increased risk of HNSCC, especially in Caucasians, alcohol drinkers and the patients with laryngeal squamous cell carcinoma. 29560133

2018
dbSNP: rs1052133
rs1052133
OGG1 ; CAMK1
0.040 GeneticVariation BEFREE In conclusion our data showed that the Ser326Cys polymorphism of the OGG1 gene may modify the risk of HNSCC associated with smoking. 20571908

2011
dbSNP: rs1052823
rs1052823
TNFAIP2
0.010 GeneticVariation BEFREE In this study, we evaluated associations of four selected SNPs (rs8126 T > C, rs710100 G > A, rs1052912 G > A and rs1052823 G > T) in the miRNA-binding sites of the 3' untranslated region (UTR) with squamous cell carcinoma of the head and neck (SCCHN) risk in 1077 patients with SCCHN and 1073 cancer-free controls in a non-Hispanic White population. 21934093

2011
dbSNP: rs1052912
rs1052912
TNFAIP2
0.010 GeneticVariation BEFREE In this study, we evaluated associations of four selected SNPs (rs8126 T > C, rs710100 G > A, rs1052912 G > A and rs1052823 G > T) in the miRNA-binding sites of the 3' untranslated region (UTR) with squamous cell carcinoma of the head and neck (SCCHN) risk in 1077 patients with SCCHN and 1073 cancer-free controls in a non-Hispanic White population. 21934093

2011
dbSNP: rs1056836
rs1056836
CYP1B1
0.010 GeneticVariation BEFREE In conclusion, our meta-analysis demonstrates that CYP1B1 Leu432Val polymorphism may be a risk factor for developing HNSCC. 24343338

2014
dbSNP: rs1057519747
rs1057519747
TP53
T 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519747
rs1057519747
TP53
G 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519816
rs1057519816
ERBB2
A 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519816
rs1057519816
ERBB2
T 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519824
rs1057519824
MET
0.010 GeneticVariation BEFREE The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions. 19639388

2009
dbSNP: rs1057519830
rs1057519830
EGFR
0.010 GeneticVariation BEFREE The occurrence of the P546S mutation needs to be evaluated in HNSCC, as a well as a prospective evaluation of cetuximab anti-tumour activity in patients with tumours harbouring the mutation. 23578570

2013
dbSNP: rs1057519847
rs1057519847
EGFR
0.010 GeneticVariation BEFREE Only one of the patients with an EGFR mutation in the primary HNSCC carried the same mutation (L858R) in the lymph node metastasis. 21953075

2012
dbSNP: rs1057519848
rs1057519848
EGFR
0.010 GeneticVariation BEFREE Only one of the patients with an EGFR mutation in the primary HNSCC carried the same mutation (L858R) in the lymph node metastasis. 21953075

2012
dbSNP: rs1057519874
rs1057519874
RAC1
A 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519874
rs1057519874
RAC1
T 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519877
rs1057519877
B2M ; PATL2
A 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519879
rs1057519879
B2M ; PATL2
C 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519879
rs1057519879
B2M ; PATL2
G 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519881
rs1057519881
CDKN2A
C 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519882
rs1057519882
CDKN2A
A 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519883
rs1057519883
CDKN2A
T 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519884
rs1057519884
CREBBP
T 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016
dbSNP: rs1057519884
rs1057519884
CREBBP
A 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016